Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement

S Petersenn, M Fleseriu, FF Casanueva… - Nature Reviews …, 2023 - nature.com
Abstract This Consensus Statement from an international, multidisciplinary workshop
sponsored by the Pituitary Society offers evidence-based graded consensus …

Clinical biology of the pituitary adenoma

S Melmed, UB Kaiser, MB Lopes, J Bertherat… - Endocrine …, 2022 - academic.oup.com
All endocrine glands are susceptible to neoplastic growth, yet the health consequences of
these neoplasms differ between endocrine tissues. Pituitary neoplasms are highly prevalent …

Standards of care for the health of transgender and gender diverse people, version 8

E Coleman, AE Radix, WP Bouman… - … journal of transgender …, 2022 - Taylor & Francis
Background: Transgender healthcare is a rapidly evolving interdisciplinary field. In the last
decade, there has been an unprecedented increase in the number and visibility of …

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

[HTML][HTML] Access to gender-affirming hormones during adolescence and mental health outcomes among transgender adults

JL Turban, D King, J Kobe, SL Reisner… - PLos one, 2022 - journals.plos.org
Objective To examine associations between recalled access to gender-affirming hormones
(GAH) during adolescence and mental health outcomes among transgender adults in the …

Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists …

AHEM Maas, G Rosano, R Cifkova… - European Heart …, 2021 - academic.oup.com
Women undergo important changes in sex hormones throughout their lifetime that can
impact cardiovascular disease risk. Whereas the traditional cardiovascular risk factors …

Opioid use disorder

J Strang, ND Volkow, L Degenhardt… - Nature reviews Disease …, 2020 - nature.com
Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by
activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that …

Assessing and addressing cardiovascular health in people who are transgender and gender diverse: a scientific statement from the American Heart Association

CG Streed Jr, LB Beach, BA Caceres, NL Dowshen… - Circulation, 2021 - Am Heart Assoc
There is growing evidence that people who are transgender and gender diverse (TGD) are
impacted by disparities across a variety of cardiovascular risk factors compared with their …

Hormone therapy, mental health, and quality of life among transgender people: a systematic review

KE Baker, LM Wilson, R Sharma… - Journal of the …, 2021 - academic.oup.com
We sought to systematically review the effect of gender-affirming hormone therapy on
psychological outcomes among transgender people. We searched PubMed, Embase, and …

Factors leading to “detransition” among transgender and gender diverse people in the United States: A mixed-methods analysis

JL Turban, SS Loo, AN Almazan, AS Keuroghlian - LGBT health, 2021 - liebertpub.com
Purpose: There is a paucity of data regarding transgender and gender diverse (TGD) people
who “detransition,” or go back to living as their sex assigned at birth. This study examined …